Drug intelligence / Profile preview

ISTA Tears

Development stage: Preclinical
Lead developer: Bausch + Lomb
Modality: Small Molecules
Administration: Ophthalmic

Overview

ISTA Tears is a sterile ophthalmic solution developed by Bausch & Lomb Incorporated. It is being evaluated in clinical trials to assess its comfort preference in patients with dry eye disease (DED).

Beyond the preview

Go deeper on ISTA Tears.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISTA Tears.

Explore the full profile